Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital

Journal of Microbiology

Volumn 54, Issue 8, 2016, Pages 551-558

  Gong, Yali ^a   Shen, Xiaodong ^a   Huang, Guangtao ^a   Zhang, Cheng ^a   Luo, Xiaoqiang ^a   Yin, Supeng ^a   Wang, Jing ^a   Hu, Fuquan ^a   Peng, Yizhi ^a   Li, Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; burn ICU; epidemiology; nosocomial infection; resistance

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; CHINA; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; HOSPITAL; HOSPITAL EQUIPMENT; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; STATISTICS AND NUMERICAL DATA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EQUIPMENT AND SUPPLIES, HOSPITAL; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS;

EID: 84980332337     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-016-6146-0     Document Type: Article

References (53)

1. Alvargonzalez, J.J., Vindel Hernando, A., Martin, M.D., Casas, C.M., Iglesias, J.O., Marin, M.F., Alvarez, M.L., Sanchez, V.B., and Mari, J.M. 2014. Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producing Acinetobacter baumannii ST92. J. Med. Microbiol. 63, 1093–1098.
2. Antunes, L.C., Visca, P., and Towner, K.J. 2014. Acinetobacter baumannii: evolution of a global pathogen. Pathog. Dis. 71, 292–301.
3. Apisarnthanarak, A., Pinitchai, U., Thongphubeth, K., Yuekyen, C., Warren, D.K., and Fraser, V.J. 2008. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin. Infect. Dis. 47, 760–767.
4. Aygün, G., Demirkiran, O., Utku, T., Mete, B., Urkmez, S., Yilmaz, M., Yasar, H., Dikmen, Y., and Oztürk, R. 2002. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J. Hosp. Infect. 52, 259–262.
5. Bai, X., Zhang, W., Tang, X., Xin, Y., Xu, Y., Sun, H., Luo, X., Pu, J., Xu, J., Xiong, Y., et al. 2016. Shiga toxin-producing Escherichia coli in plateau pika (Ochotona curzoniae) on the Qinghai- Tibetan plateau, China. Front. Microbiol. 7, 375.
6. Bartual, S.G., Seifert, H., Hippler, C., Luzon, M.A., Wisplinghoff, H., and Rodriguez-Valera, F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43, 4382–4390.
7. Bertini, A., Poirel, L., Bernabeu, S., Fortini, D., Villa, L., Nordmann, P., and Carattoli, A. 2007. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 2324–2328.
8. Chang, Y., Luan, G., Xu, Y., Wang, Y., Shen, M., Zhang, C., Zheng, W., Huang, J., Yang, J., Jia, X., et al. 2015. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front. Microbiol. 6, 910.
9. Chen, H., Yuehua, X., Shen, W., Zhou, H., Zhou, L., and Li, Z. 2013. Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: a multicenter study. Mol. Med. Rep. 7, 21–25.
10. Corbella, X., Montero, A., Pujol, M., Dominguez, M.A., Ayats, J., Argerich, M.J., Garrigosa, F., Ariza, J., and Gudiol, F. 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol. 38, 4086–4095.
11. Coyne, S., Courvalin, P., and Perichon, B. 2011. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55, 947–953.
12. Davis, M.A., Besser, T.E., Orfe, L.H., Baker, K.N., Lanier, A.S., Broschat, S.L., New, D., and Call, D.R. 2011. Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use. Appl. Environ. Microbiol. 77, 3293–3299.
13. Dijkshoorn, L., Nemec, A., and Seifert, H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939–951.
14. Drawz, S.M. and Bonomo, R.A. 2010. Three decades of ß-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160–201.
15. Evans, B.A. and Amyes, S.G. 2014. OXA ß-lactamases. Clin. Microbiol. Rev. 27, 241–263.
16. Fu, Y., Zhou, J., Zhou, H., Yang, Q., Wei, Z., Yu, Y., and Li, L. 2010. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J. Antimicrob. Chemother. 65, 644–650.
17. Gallego, L. and Towner, K.J. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J. Med. Microbiol. 50, 71–77.
18. Gao, J., Zhao, X., Bao, Y., Ma, R., Zhou, Y., Li, X., Chai, T., and Cai, Y. 2014. Antibiotic resistance and OXA-type carbapenemasesencoding genes in airborne Acinetobacter baumannii isolated from burn wards. Burns 40, 295–299.
19. Gong, Y., Chen, J., Liu, C., Zhang, C., Luo, X., and Peng, Y. 2014. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 40, 402–407.
20. OXA-51-like genes. J. Clin. Microbiol. 48, 2476–2483.
21. OXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. J. Med. Microbiol. 60, 337–341.
22. Higgins, P.G., Dammhayn, C., Hackel, M., and Seifert, H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65, 233–238.
23. Hindler, J.F. and Stelling, J. 2007. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the clinical and laboratory standards institute. Clin. Infect. Dis. 44, 867–873.
24. Howard, A., O’Donoghue, M., Feeney, A., and Sleator, R.D. 2012. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3, 243–250.
25. Huang, G., Shen, X., Gong, Y., Dong, Z., Zhao, X., Shen, W., Wang, J., Hu, F., and Peng, Y. 2014. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1). BMC Infect. Dis. 14, 681.
26. Huang, Y., Zhong, L., Zhang, X., Hu, H., Li, Y., Yang, X., Feng, L., Huang, X., and Tian, G. 2015. NDM-1-producing Citrobacter freundii, Escherichia coli, and Acinetobacter baumannii identified from a single patient in China. Antimicrob. Agents Chemother. 59, 5073–5077.
27. Ji, S., Chen, Y., Ruan, Z., Fu, Y., Ji, J., Fu, Y., Wang, H., and Yu, Y. 2014. Prevalence of carbapenem-hydrolyzing claßs D ß-lactamase genes in Acinetobacter spp. isolates in China. Eur. J. Clin. Microbiol. Infect. Dis. 33, 989–997.
28. Le Minh, V., Thi Khanh Nhu, N., Vinh Phat, V., Thompson, C., Huong Lan, N.P., Thieu Nga, T.V., Thanh Tam, P.T., Tuyen, H.T., Hoang Nhu, T.D., Van Hao, N., et al. 2015. In vitro activity of colistin in antimicrobial combination against carbapenemresistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam. J. Med. Microbiol. 64, 1162–1169.
29. Liu, Y. and Liu, X. 2015. Detection of AmpC ß-lactamases in Acinetobacter baumannii in the Xuzhou region and analysis of drug resistance. Exp. Ther. Med. 10, 933–936.
30. Ma, Z., Zhou, L., Wang, H., and Luo, L. 2015. Investigation on the genomic diversity of OXA from isolated Acinetobacter baumannii. Int. J. Clin. Exp. Med. 8, 4429–4432.
31. Mahgoub, S., Ahmed, J., and Glatt, A.E. 2002. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am. J. Infect. Control. 30, 386–390.
32. Martineau, F., Picard, F.J., Lansac, N., Menard, C., Roy, P.H., Ouellette, M., and Bergeron, M.G. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44, 231–238.
33. Öncül, O., Öksüz, S., Acar, A., Ülkür, E., Turhan, V., Uygur, F., Ulçay, A., Erdem, H., Özyurt, M., and Görenek, L. 2014. Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance. Burns 40, 835–841.
34. Papp-Wallace, K.M., Endimiani, A., Taracila, M.A., and Bonomo, R.A. 2011. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55, 4943–4960.
35. Park, G.C., Choi, J.A., Jang, S.J., Jeong, S.H., Kim, C.M., Choi, I.S., Kang, S.H., Park, G., and Moon, D.S. 2016. In vitro interactions of antibiotic combinations of colistin, tigecycline, and doripenem against extensively drug-resistant and multidrug-resistant Acinetobacter baumannii. Ann. Lab. Med. 36, 124–130.
36. Peleg, A.Y. and Hooper, D.C. 2010. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362, 1804–1813.
37. Peleg, A.Y., Seifert, H., and Paterson, D.L. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538–582.
38. Perez, F., Hujer, A.M., Hujer, K.M., Decker, B.K., Rather, P.N., and Bonomo, R.A. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471–3484.
39. Pfaller, M.A., Boyken, L., Hollis, R.J., Messer, S.A., Tendolkar, S., and Diekema, D.J. 2005. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods. J. Clin. Microbiol. 43, 3807–3810.
40. Potron, A., Poirel, L., and Nordmann, P. 2015. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int. J. Antimicrob. Agents 45, 568–585.
41. Povilonis, J., Seputiene, V., Krasauskas, R., Juskaite, R., Miskinyte, M., Suziedelis, K., and Suziedeliene, E. 2013. Spread of carbapenem- resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA-72 carbapenemase in Lithuanian hospitals. J. Antimicrob. Chemother. 68, 1000–1006.
42. Rezaei, E., Safari, H., Naderinasab, M., and Aliakbarian, H. 2011. Common pathogens in burn wound and changes in their drug sensitivity. Burns 37, 805–807.
43. Ruan, Z., Chen, Y., Jiang, Y., Zhou, H., Zhou, Z., Fu, Y., Wang, H., Wang, Y., and Yu, Y. 2014. Wide distribution of CC92 carbapenem- resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int. J. Antimicrob. Agents 42, 322–328.
44. Runnegar, N., Sidjabat, H., Goh, H.M., Nimmo, G.R., Schembri, M.A., and Paterson, D.L. 2010. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48, 4051–4056.
45. Takahashi, A., Yomoda, S., Kobayashi, I., Okubo, T., Tsunoda, M., and Iyobe, S. 2000. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J. Clin. Microbiol. 38, 526–529.
46. Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., and Swaminathan, B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233–2239.
47. Tiwari, V., Roy, R., and Tiwari, M. 2015. Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens. Front. Microbiol. 6, 618.
48. Tomaschek, F., Higgins, P.G., Stefanik, D., Wisplinghoff, H., and Seifert, H. 2016. Head-to-head comparison of two multi-locus sequence typing (MLST) schemes for characterization of Acinetobacter baumannii outbreak and sporadic isolates. PLoS One 11, e0153014.
49. OXA-23-like in Acinetobacter baumannii clinical isolates in southern China: an 8-year study. PLoS One 10, e0137174.
50. Ying, C., Li, Y., Wang, Y., Zheng, B., and Yang, C. 2015. Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination. J. Antibiot. (Tokyo) 68, 562–567.
51. Zervosen, A., Sauvage, E., Frere, J.M., Charlier, P., and Luxen, A. 2012. Development of new drugs for an old target: the penicillin binding proteins. Molecules 17, 12478–12505.
52. OXA-23 in Guangzhou, China. Microb. Drug Resist. 21, 386–390.
53. Zorgani, A., Abofayed, A., Glia, A., Albarbar, A., and Hanish, S. 2015. Prevalence of device-associated nosocomial infections caused by Gram-negative bacteria in a trauma intensive care unit in Libya. Oman Med. J. 30, 270–275.